Antimicrobial and Resource Utilization with T2 Magnetic Resonance for Rapid Diagnosis of Bloodstream Infections: Systematic Review with Meta-analysis of Controlled Studies

Last updated: 19th August, 2021

Products are for professional/laboratory use

Expert Review of Medical Devices, a peer-reviewed medical journal, published meta-analysis findings confirming that the utilization of T2 Magnetic Resonance (T2MR®) technology for identification of bloodstream infections (BSIs) provides faster time to detection, faster transition to targeted microbial therapy, faster de-escalation of empirical therapy, and shorter Intensive Care Unit (ICU) and hospital stay versus the current blood culture standard of care1.
 


 

The current standard of care for patients suspected of BSIs or sepsis requires 1-7 days to provide species ID and susceptibility results. This information is used by clinicians to target therapy and optimize treatment of the identified infectious pathogen.

The T2Bacteria® and T2Candida® Panels are the first and only FDA cleared products able to provide results directly from whole blood in three to five hours, often before the second dose of empiric antibiotic therapy is administered, without the need to wait days for a positive blood culture.


Recent and upcoming T2 Biosystems Scientific Presentations

Culture Independent Rapid Diagnostics Impact on Sepsis Management
June 20, 2021, 12:30 PM – 1:30 PM (on-demand)
Speakers: Dr. James Snyder, Dr. Todd McCarty, Dr. Aparna Ahuja
Breaking New Ground in Sepsis Diagnosis and Management with Non-Culture-Based Tests
June 23, 2021, 2:45-3:15 ET
Speakers: Dr. Debra Goff, Dr. Aparna Ahuja
The crucial role of rapid diagnostics in the early detection of secondary bacterial and fungal infections complicating COVID-19
July 12, 2021, 9:30-10:30 CET
Speakers: Dr. Thomas Walsh, Dr. Tamara Seitz, Dr. Aparna Ahuja

References

  1. Giannella, Maddalena, et al. “Antimicrobial and Resource Utilization with T2 Magnetic Resonance for Rapid Diagnosis of Bloodstream Infections: Systematic Review with Meta-analysis of Controlled Studies.” Expert Review of Medical Devicesjust-accepted (2021).

 



Request a Quote

Request Quote

Go BackGo Back
Top